MICRO LABS LTD INDIA
GenericsMICRO LABS LTD INDIA is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.
MICRO LABS LTD INDIA's Key Drugs
MICRO LABS LTD INDIA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MICRO LABS LTD INDIA's Recent FDA Approvals
New NDA/BLA approvals for MICRO LABS LTD INDIA over the last two years — novel drugs only, excluding generics and label supplements.
MICRO LABS LTD INDIA's Therapeutic Areas
MICRO LABS LTD INDIA's approved drugs and pipeline span 3 therapeutic areas, led by Cardiovascular and Neurology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MICRO LABS LTD INDIA's Top Competitors
MICRO LABS LTD INDIA's closest competitors by therapeutic-area and drug-target overlap include Novartis, UPJOHN, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MICRO LABS LTD INDIA Pipeline Snapshot
Active clinical trials for MICRO LABS LTD INDIA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2012-12-14
- Latest
- 2026-06-18
- Applications
- 14